The progress in diagnosis and treatment of ovarian cancer
Lingling Tong
Abstract
Lingling Tong
Abstract
The early diagnosis of ovarian cancer has been relied on the classical tumor marker cancer antigen 125 (CA_125),as well as transvaginal ultrasonography (TVS).Recently,the new markers of human epididymis protein 4 (HE_4) and proteomics become very important for monitoring ovarian cancer pathogenesis,treatment,clinical outcome and recurrence.The normative and thoroughness of the initial surgery for ovarian cancer are critical to the proper surgery and chemotherapy.Early ovarian cancer should conduct a comprehensive staging operation.When necessary,the re-staging should be done before chemotherapy.In advanced stage of ovarian cancer,it had better to do cytoreductive surgery,in combination with neoadjuvant chemotherapy.After early diagnosis and standard treatment,the survival rate of ovarian cancer has been increased significantly,however,gynecological oncologist can not ignore the high relapse rate and mortality.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The early diagnosis of ovarian cancer has been relied on the classical tumor marker cancer antigen 125 (CA_125),as well as transvaginal ultrasonography (TVS).Recently,the new markers of human epididymis protein 4 (HE_4) and proteomics become very important for monitoring ovarian cancer pathogenesis,treatment,clinical outcome and recurrence.The normative and thoroughness of the initial surgery for ovarian cancer are critical to the proper surgery and chemotherapy.Early ovarian cancer should conduct a comprehensive staging operation.When necessary,the re-staging should be done before chemotherapy.In advanced stage of ovarian cancer,it had better to do cytoreductive surgery,in combination with neoadjuvant chemotherapy.After early diagnosis and standard treatment,the survival rate of ovarian cancer has been increased significantly,however,gynecological oncologist can not ignore the high relapse rate and mortality.
Key concepts: Medicine, Ovarian cancer, Chemotherapy, Stage (stratigraphy), Oncology, Cancer antigen, Cancer, Cytoreductive surgery